Brokers next on the hit list

Government and regulators target mortgage brokers and stockbrokers remuneration models

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Mortgage brokers and stockbrokers appear likely to feel the heat from the government and the regulators, after the financial advice industry had its day in the sun, thanks to the Financial System Inquiry (FSI).

Financial advisers and planners have come under scrutiny following several scandals involving a number of Australia's largest wealth management companies. IOOF Holdings Limited (ASX: IFL), the big four banks Australia and New Zealand Banking Group (ASX: ANZ), Commonwealth Bank of Australia (ASX: CBA), National Australia Bank Ltd (ASX: NAB) and Westpac Banking Corp (ASX: WBC) and Macquarie Group Ltd (ASX: MQG) have all felt the heat over that.

Advisers will be required to hold a degree, pass an exam, undertake continuous professional development, subscribe to a code of ethics and undertake a professional year.

In its response to the FSI report, the government has also tasked the Australian Securities and Investments Commission (ASIC) to take on mortgage brokers and their remuneration structure, with the regulator already reviewing stockbrokers' pay structures.

Mortgage brokers and financial planners will be required to disclose who owns them, while commissions for selling life insurance are also under fire. In many cases, brokers and advisers receive between 100% and 130% of the first full year's premium as a commission, and between 10%% and 13% of the premium each year following that.

One of the other issues ASIC is tackling is whether industry commissions encourage clients to trade more than they really need to. According to the FSI, only Australia and the US allow stockbrokers to take a commission on the brokerage fees they earn for writing higher volume. Most other financial centres pay their stockbrokers a salary and a discretionary bonus.

This is an age-old problem – the power of incentives – and it's not limited to the stockbroking industry. Stockbrokers make money from trading, so the more their clients trade, the more revenue they rake in. The more revenue a broker makes for the firm, the more he gets paid – so the carrot is there for brokers to naturally encourage clients to churn stocks.

Stockbrokers Association of Australia boss Andrew Green naturally disagrees, saying that ASIC's market integrity rules manage the risk of churning.

But as Warren Buffett's partner Charlie Munger says, "Never underestimate the power of incentives".

Simply removing the incentive should result in a better outcome for all parties.

Tackling stockbrokers' commissions is likely to pit ASIC head on with investment banks and their brokerage arms – and that's not exactly going to be an easy task to win.

Brokers had secured an exclusion from the Future of Financial Advice laws in 2013, as shares were considered product neutral, meaning advisers had no incentive to push certain stocks.

In most cases that is likely, but in some cases, brokers may be incentivised to push stocks to some clients, above others. For example, one client may wish to sell a large block of stock, which could see brokers push other clients to buy, perhaps unnecessarily, or at the expense of other stocks. But it's a very fine line.

Foolish takeaway

In the health care sector, particularly in the US, a move is underway to link medical practitioners' remuneration with patient outcomes, rather than on a pay-for-service model. In simple terms, it means doctors get paid for the results they achieve for their patients, hopefully reducing wastage and saving billions of dollars.

Maybe Australia needs to adopt a similar model for stockbrokers and mortgage brokers (not to mention financial advisers), where their remuneration structure is linked to the financial outcomes of their clients.

Motley Fool contributor Mike King doesn't own shares in any companies mentioned. You can follow Mike on Twitter @TMFKinga Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »